Compare AMTX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMTX | STIM |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 136.3M |
| IPO Year | N/A | 2018 |
| Metric | AMTX | STIM |
|---|---|---|
| Price | $1.72 | $1.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $17.00 | $7.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $201,323,000.00 | $129,873,000.00 |
| Revenue This Year | $6.44 | $105.70 |
| Revenue Next Year | $114.64 | $11.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $1.22 | $0.96 |
| 52 Week High | $4.17 | $5.92 |
| Indicator | AMTX | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 29.22 |
| Support Level | $1.50 | $2.01 |
| Resistance Level | $1.77 | $1.53 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 30.00 | 20.00 |
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.